2025 annual financial data
InMed Pharmaceuticals 2025 Net margin
Direct answer
Net margin was -165.14%.
Operating income was -7,917,995 USD and net income was -8,162,133 USD.
Operating cash flow was -7,766,951 USD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,942,633 USD
- Operating income
- -7,917,995 USD
- Net income
- -8,162,133 USD
- Operating cash flow
- -7,766,951 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all InMed Pharmaceuticals financial years